Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future by Margaret G. Lamb, Hemalatha G. Rangarajan, Brian P. Tullius, Dean A. Lee

Get full text

993 Knockout of DNAM-1 competing inhibitory receptors enhances natural killer cell anti-tumor functions against neuroblastoma by Jeremiah L Oyer, Tayler J Croom-Perez, Liza D Robles-Carrillo, Faqrul Hasan, Sanjana Kumar, Brendan W Andersen, Javier A Rivera-Huertas, Brian P Tullius, Alicja J Copik

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy by Ezgi Elmas, Ezgi Elmas, Noushin Saljoughian, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P. Tullius, Kinnari Sorathia, Robin J. Nakkula, Dean A. Lee, Dean A. Lee, Meisam Naeimi Kararoudi, Meisam Naeimi Kararoudi, Meisam Naeimi Kararoudi

Get full text

Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies by Dean A Lee, Jeremiah L Oyer, Md Faqrul Hasan, Tayler J Croom-Perez, Liza D Robles-Carrillo, Sanjana Kumar, Brendan W Andersen, Brian P Tullius, Alicja J Copik, Amanda R Campbell, Thomas A Dieffenthaller, Catherine A Cash, Jonathan E Eloriaga, Meisam Naeimi Kararoudi

Get full text